ARQT- Arcutis Biotherapeutics, Inc.

Name: Arcutis Biotherapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Arcutis Biotherapeutics, Inc. (ARQT) has 13 insiders with recent SEC Form 4 filings, including 9 buys and 4 sells. ARQT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Watanabe Todd	740.5K	$19.88M	-
Other	Edwards Larry Todd	150.2K	$4.03M	-
Other	Matsuda Masaru	127.6K	$3.43M	-
Other	Burnett Patrick	120.2K	$3.23M	-
CFO	Vairavan Latha	86.0K	$2.31M	-

Activity

Buys and sells only

Transactions

10 filings · page 5

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 18, 2025	Welgus Howard G.61	-	Sell	10,139	$13.37	$135,573.64	-8.5%	+24.1%	+91.7%
Jun 13, 2025	Heron Patrick J87	-	Buy	2,646	$13.08	$34,610.47	+10.7%	+31.7%	-
Jun 5, 2025	Heron Patrick J87	Director	Buy	2,268	$13.34	$30,246.73	+4.8%	+18.0%	+57.1%
May 28, 2025	Matsuda Masaru51	See Remarks	Sell	1,800	$13.78	$24,806.52	-0.9%	+16.6%	+57.9%
May 22, 2025	Heron Patrick J87	Director	Buy	5,040	$13.66	$68,821.20	+13.4%	+15.6%	+52.7%
May 19, 2025	Edwards Larry Todd	See Remarks	Sell	7,451	$14.07	$104,849.73	-3.9%	+14.3%	+33.2%
May 15, 2025	Heron Patrick J87	Director	Buy	2,520	$13.62	$34,316.86	+16.8%	+14.7%	+56.4%
May 14, 2025	Heron Patrick J87	Director	Buy	8,674	$13.76	$119,351.93	+57.9%	+8.4%	+58.6%
May 9, 2025	Heron Patrick J87	Director	Buy	6,300	$13.60	$85,691.34	New	+4.4%	-
May 8, 2025	Burnett Patrick	See Remarks	Sell	3,871	$13.59	$52,623.15	-3.2%	+13.7%	+56.6%

← PrevPage 5Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC